Evaluation of Preoperative Investigations in Patients With Liver Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00408122
: December 6, 2006
Last Update Posted
: October 16, 2014
Odense University Hospital
Information provided by (Responsible Party):
Alan Patrick Ainsworth, Odense University Hospital
The aim of the study is to evaluate the diagnostic procedures emission tomography in combination with a CT scan (PET/CT) and endoscopic ultrasonography (EUS) in the preoperative evaluation of resectability of patients with primary or secondary liver cancers.
Evaluation of Positron Emission Tomography/ CT Scan, Endoscopic Ultrasono¬Graphy, and Laparoscopic Ultrasonography in the Preoperative Assess¬Ment of Resectability in Patients With Primary and Secondary Liver Cancer
Study Start Date
Primary Completion Date
Study Completion Date
Resource links provided by the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
PAtients with liver tumors
all patients who are referred to The Department of Surgery, Odense University Hospital, for surgical treatment of suspected or biopsy proven primary or secondary liver cancer.
age less than 18 years
patients who are not fit for liver surgery because of co-morbidity
patients for whom the extra investigations in the study are considered to give an increased risk because of co-morbidity such as
Patients with s-creatinin > 150 micromol/l
Patients who take peroral antidiabetic drugs or have a poorly regulated diabetes mellitus
patients who do not understand the patient information